NSBCC: NanoSystems Biology Cancer Center - People

Professor James R. Heath

Wed, 4 Jan 2006 10:14:59 -0800

James R. Heath is the Elizabeth W. Gilloon Professor and Professor of Chemistry at Caltech, and Professor of Molecular & Medical Pharmacology at UCLA, and Director of the National Cancer Institutes NSB Cancer Center.

Dr. Leroy Hood

Sun, 25 Dec 2005 11:19:24 -0800

Leroy Hood’s research has focused on the study of molecular immunology, biotechnology, and genomics. His professional career began at Caltech where he and his colleagues pioneered four instruments—the DNA gene sequencer and synthesizer, and the protein synthesizer and sequencer—which comprise the technological foundation for contemporary molecular biology.

Professor Michael Phelps

Sun, 25 Dec 2005 09:59:18 -0800

Michael Phelps, the Norton Simon Professor and Chair of the UCLA Department of Molecular and Medical Pharmacology, has been on the faculty of the University of California since 1976. He is actively engaged in medical research, educational programs and multimedia technologies at UCLA. Dr. Phelps uniquely holds six academic positions at UCLA. In addition to serving as the Departmental Chairman and holding an endowed professorship, he is also the Director of the Crump Institute for Molecular Imaging, Professor of Biomathematics, the Director of the Institute for Molecular Medicine and the Chief of Nuclear Medicine.

Professor Robert H. Grubbs

Thu, 22 Dec 2005 19:27:22 -0800

Dr. Robert H. Grubbs is the Victor and Elizabeth Atkins Professor of Chemistry at the California Institute of Technology, Pasadena, California, USA, where he has been a faculty member since 1978. Before moving to Caltech, he was at Michigan State University from 1969 to 1978 achieving the rank of Associate Professor.

Mark Davis Discusses Early Clinical Trial Results

Wed, 28 May 2008 11:42:44 -0700

In a Watson lecture on May 14, Mark Davis, NSBCC investigator and Caltech's Schlinger Professor of Chemical Engineering. Davis, also a member of the experimental therapeutics program at the City of Hope's Comprehensive Cancer Center, explained how nanoparticle medicines, or nanomedicines, have the potential to change the way cancer is treated.

NSBCC Mourns Passing of Hamilton Jordan, External Advisory Board Member

Wed, 21 May 2008 09:45:54 -0700

Hamilton Jordan, good friend and NSBCC External Advisory Board Member, died in his home of cancer on Tuesday, May 20, 2008.

Roy Doumani

Wed, 18 Jan 2006 09:01:12 -0800

Roy Doumani, a survivor of prostate cancer, is a native of Los Angeles. He graduated from UCLA with a degree in Business and Finance and received a law degree from the University of Southern California. He is a member of the California NanoSystems Institute (CNSI) Advisory and Oversight Board. Mr. Doumani holds the position of Professor of Molecular and Medical Pharmacology at the David Geffen School of Medicine at UCLA. He also serves as co-chairman of the Zhejiang California NanoSystems Institute (ZCNI) and is chairman of the Business Advisory Board for the governor of Zhejiang Province, China.

Ruedi Aebersold, PhD

Tue, 17 Jan 2006 19:34:52 -0800

Dr. Ruedi Aebersold, one of the pioneers in the field of proteomics, is known for developing a series of methods that have found wide application in analytical protein chemistry and proteomics. Most recently, his group developed a method for the rapid identification and accurate quantification of cellular proteins, i.e. for the generation of cellular "protein profiles";. The method is based on a new class of reagents termed Isotope Coded Affinity Tags or ICAT reagents, and mass spectrometry.

Michael Roukes, PhD

Tue, 17 Jan 2006 19:30:39 -0800

Hong Wu, MD, PhD

Sat, 7 Jan 2006 09:50:09 -0800

Hong Wu is a Professor of Molecular and Medical Pharmacology at UCLA School of Medicine, and a member of UCLA Molecular Biology Institute and Jonsson Comprehensive Cancer Center. She is the Director of the UCLA Molecular Genetics Technology Center and the co-director of Cancer Stem Cell Program area of the newly formed UCLA Institute for Stem Cell Biology and Medicine.

Hartmuth Kolb, PhD

Sat, 7 Jan 2006 09:46:51 -0800

Paul Mischel, MD

Sat, 7 Jan 2006 09:40:28 -0800

Paul S. Mischel is a neuropathologist and cancer biologist who has served on the UCLA School of Medicine Faculty since joining the Department of Pathology and Laboratory Medicine in 1998. He became an associate professor in 2004. Dr. Mischel graduated with a B.A. in Philosophy from the University of Pennsylvania in 1984. He earned his M.D. from Cornell University Medical College in 1991, graduating with Alpha Omega Alpha Honors. He did his residency training in Anatomic Pathology and his fellowship in Neuropathology at UCLA.

Judith Gasson, PhD

Sat, 7 Jan 2006 09:36:22 -0800

Judith Gasson, Ph.D., became the director of UCLA's Jonsson Comprehensive Cancer Center on Sept. 15, 1995. She is a molecular biologist and is responsible for one of only 39 institutions designated as comprehensive cancer centers by the National Cancer Institute.

Tom Graeber, PhD

Fri, 6 Jan 2006 16:37:58 -0800

Tom Graeber, PhD is faculty in the Department of Molecular and Medical Pharmacology and a member of the Crump Institute for Molecular Imaging at UCLA, and is a National Human Genome Research Institute (NHGRI) Genome Scholar. His background includes physics, cancer biology, signal transduction, computational biology and proteomics, and he is now building experimental and computational approaches to studying cancer signaling from a systems perspective

Jeff Ranish, PhD

Wed, 4 Jan 2006 10:19:11 -0800

Dr. Jeff Ranish joined the ISB faculty in 2005. He has a strong background in the disciplines of proteomics, molecular biology and biochemistry. He has a longstanding interest in understanding how protein’s function in the context of biological systems. Dr. Ranish pursues this goal by developing and applying state of the art proteomics technologies to probe the composition of macromolecular complexes, with a focus on transcriptional regulatory complexes.